Cost–utility analysis of high-dose melphalan with...

Cost–utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma

Nina Gulbrandsen, Finn Wisløff, Erik Nord, Stig Lenhoff, Martin Hjorth, Jan Westin, Nordic Myeloma Study Group
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
66
Year:
2001
Language:
english
Pages:
9
DOI:
10.1034/j.1600-0609.2001.066005328.x
File:
PDF, 101 KB
english, 2001
Conversion to is in progress
Conversion to is failed